General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Lilly(MODEST) RESEARCH/RESEARCH GRANTS: Actelion(SIGNIFICANT), Bayer(SIGNIFICANT), lilly(NONE), Pfizer(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Actelion(SIGNIFICANT)

View Full Disclosure